The global market for Sexually Transmitted Disease (STD) Diagnosis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Sexually Transmitted Disease (STD) Diagnosis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Sexually Transmitted Disease (STD) Diagnosis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Sexually Transmitted Disease (STD) Diagnosis in Government organizations is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Sexually Transmitted Disease (STD) Diagnosis include Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical, Biocartis, BioMerieux, Bio-Rad, Cepheid, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Disease (STD) Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Disease (STD) Diagnosis.

The Sexually Transmitted Disease (STD) Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sexually Transmitted Disease (STD) Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sexually Transmitted Disease (STD) Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Sexually Transmitted Disease (STD) Diagnosis Market Report

Report Metric	Details
Report Name	Sexually Transmitted Disease (STD) Diagnosis Market
Segment by Type	Chlamydia testing Syphilis testing Gonorrhoea testing Herpes simplex virus testing Human papilloma virus testing Human immunodeficiency virus testing
Segment by Application	Government organizations Hospitals Diagnostic clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical, Biocartis, BioMerieux, Bio-Rad, Cepheid, Danaher, DiaSorin, Quidel, GenMark Diagnostics, Hologic, OraSure Technologies, Qualigen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sexually Transmitted Disease (STD) Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sexually Transmitted Disease (STD) Diagnosis Market report?

Ans: The main players in the Sexually Transmitted Disease (STD) Diagnosis Market are Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical, Biocartis, BioMerieux, Bio-Rad, Cepheid, Danaher, DiaSorin, Quidel, GenMark Diagnostics, Hologic, OraSure Technologies, Qualigen

What are the Application segmentation covered in the Sexually Transmitted Disease (STD) Diagnosis Market report?

Ans: The Applications covered in the Sexually Transmitted Disease (STD) Diagnosis Market report are Government organizations, Hospitals, Diagnostic clinics

What are the Type segmentation covered in the Sexually Transmitted Disease (STD) Diagnosis Market report?

Ans: The Types covered in the Sexually Transmitted Disease (STD) Diagnosis Market report are Chlamydia testing, Syphilis testing, Gonorrhoea testing, Herpes simplex virus testing, Human papilloma virus testing, Human immunodeficiency virus testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Chlamydia testing

1.2.3 Syphilis testing

1.2.4 Gonorrhoea testing

1.2.5 Herpes simplex virus testing

1.2.6 Human papilloma virus testing

1.2.7 Human immunodeficiency virus testing

1.3 Market by Application

1.3.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Government organizations

1.3.3 Hospitals

1.3.4 Diagnostic clinics

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Perspective (2020-2031)

2.2 Global Sexually Transmitted Disease (STD) Diagnosis Growth Trends by Region

2.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Region (2020-2025)

2.2.3 Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Region (2026-2031)

2.3 Sexually Transmitted Disease (STD) Diagnosis Market Dynamics

2.3.1 Sexually Transmitted Disease (STD) Diagnosis Industry Trends

2.3.2 Sexually Transmitted Disease (STD) Diagnosis Market Drivers

2.3.3 Sexually Transmitted Disease (STD) Diagnosis Market Challenges

2.3.4 Sexually Transmitted Disease (STD) Diagnosis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue

3.1.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue (2020-2025)

3.1.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Players (2020-2025)

3.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Sexually Transmitted Disease (STD) Diagnosis Revenue

3.4 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio

3.4.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2024

3.5 Global Key Players of Sexually Transmitted Disease (STD) Diagnosis Head office and Area Served

3.6 Global Key Players of Sexually Transmitted Disease (STD) Diagnosis, Product and Application

3.7 Global Key Players of Sexually Transmitted Disease (STD) Diagnosis, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Sexually Transmitted Disease (STD) Diagnosis Breakdown Data by Type

4.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Type (2020-2025)

4.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2026-2031)

5 Sexually Transmitted Disease (STD) Diagnosis Breakdown Data by Application

5.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Application (2020-2025)

5.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size (2020-2031)

6.2 North America Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025)

6.4 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size (2020-2031)

7.2 Europe Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025)

7.4 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size (2020-2031)

8.2 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2020-2025)

8.4 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size (2020-2031)

9.2 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025)

9.4 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size (2020-2031)

10.2 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025)

10.4 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Introduction

11.1.4 Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.1.5 Abbott Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Introduction

11.2.4 Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Introduction

11.3.4 Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 Aposcience

11.4.1 Aposcience Company Details

11.4.2 Aposcience Business Overview

11.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Introduction

11.4.4 Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.4.5 Aposcience Recent Development

11.5 BCR Diagnostics

11.5.1 BCR Diagnostics Company Details

11.5.2 BCR Diagnostics Business Overview

11.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction

11.5.4 BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.5.5 BCR Diagnostics Recent Development

11.6 BD Medical

11.6.1 BD Medical Company Details

11.6.2 BD Medical Business Overview

11.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Introduction

11.6.4 BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.6.5 BD Medical Recent Development

11.7 Biocartis

11.7.1 Biocartis Company Details

11.7.2 Biocartis Business Overview

11.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Introduction

11.7.4 Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.7.5 Biocartis Recent Development

11.8 BioMerieux

11.8.1 BioMerieux Company Details

11.8.2 BioMerieux Business Overview

11.8.3 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Introduction

11.8.4 BioMerieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.8.5 BioMerieux Recent Development

11.9 Bio-Rad

11.9.1 Bio-Rad Company Details

11.9.2 Bio-Rad Business Overview

11.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Introduction

11.9.4 Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.9.5 Bio-Rad Recent Development

11.10 Cepheid

11.10.1 Cepheid Company Details

11.10.2 Cepheid Business Overview

11.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Introduction

11.10.4 Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.10.5 Cepheid Recent Development

11.11 Danaher

11.11.1 Danaher Company Details

11.11.2 Danaher Business Overview

11.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Introduction

11.11.4 Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.11.5 Danaher Recent Development

11.12 DiaSorin

11.12.1 DiaSorin Company Details

11.12.2 DiaSorin Business Overview

11.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Introduction

11.12.4 DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.12.5 DiaSorin Recent Development

11.13 Quidel

11.13.1 Quidel Company Details

11.13.2 Quidel Business Overview

11.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Introduction

11.13.4 Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.13.5 Quidel Recent Development

11.14 GenMark Diagnostics

11.14.1 GenMark Diagnostics Company Details

11.14.2 GenMark Diagnostics Business Overview

11.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction

11.14.4 GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.14.5 GenMark Diagnostics Recent Development

11.15 Hologic

11.15.1 Hologic Company Details

11.15.2 Hologic Business Overview

11.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Introduction

11.15.4 Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.15.5 Hologic Recent Development

11.16 OraSure Technologies

11.16.1 OraSure Technologies Company Details

11.16.2 OraSure Technologies Business Overview

11.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Introduction

11.16.4 OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.16.5 OraSure Technologies Recent Development

11.17 Qualigen

11.17.1 Qualigen Company Details

11.17.2 Qualigen Business Overview

11.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Introduction

11.17.4 Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

11.17.5 Qualigen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott

Roche

Thermo Fisher Scientific

List of Tables

Table 1. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Chlamydia testing

Table 3. Key Players of Syphilis testing

Table 4. Key Players of Gonorrhoea testing

Table 5. Key Players of Herpes simplex virus testing

Table 6. Key Players of Human papilloma virus testing

Table 7. Key Players of Human immunodeficiency virus testing

Table 8. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2020-2025)

Table 12. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2026-2031)

Table 14. Sexually Transmitted Disease (STD) Diagnosis Market Trends

Table 15. Sexually Transmitted Disease (STD) Diagnosis Market Drivers

Table 16. Sexually Transmitted Disease (STD) Diagnosis Market Challenges

Table 17. Sexually Transmitted Disease (STD) Diagnosis Market Restraints

Table 18. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Players (2020-2025)

Table 20. Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2024)

Table 21. Ranking of Global Top Sexually Transmitted Disease (STD) Diagnosis Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Sexually Transmitted Disease (STD) Diagnosis, Headquarters and Area Served

Table 24. Global Key Players of Sexually Transmitted Disease (STD) Diagnosis, Product and Application

Table 25. Global Key Players of Sexually Transmitted Disease (STD) Diagnosis, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2020-2025)

Table 29. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type (2026-2031)

Table 31. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2020-2025)

Table 33. Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2026-2031)

Table 35. North America Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2026-2031) & (US$ Million)

Table 50. Abbott Company Details

Table 51. Abbott Business Overview

Table 52. Abbott Sexually Transmitted Disease (STD) Diagnosis Product

Table 53. Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 54. Abbott Recent Development

Table 55. Roche Company Details

Table 56. Roche Business Overview

Table 57. Roche Sexually Transmitted Disease (STD) Diagnosis Product

Table 58. Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 59. Roche Recent Development

Table 60. Thermo Fisher Scientific Company Details

Table 61. Thermo Fisher Scientific Business Overview

Table 62. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product

Table 63. Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 64. Thermo Fisher Scientific Recent Development

Table 65. Aposcience Company Details

Table 66. Aposcience Business Overview

Table 67. Aposcience Sexually Transmitted Disease (STD) Diagnosis Product

Table 68. Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 69. Aposcience Recent Development

Table 70. BCR Diagnostics Company Details

Table 71. BCR Diagnostics Business Overview

Table 72. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product

Table 73. BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 74. BCR Diagnostics Recent Development

Table 75. BD Medical Company Details

Table 76. BD Medical Business Overview

Table 77. BD Medical Sexually Transmitted Disease (STD) Diagnosis Product

Table 78. BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 79. BD Medical Recent Development

Table 80. Biocartis Company Details

Table 81. Biocartis Business Overview

Table 82. Biocartis Sexually Transmitted Disease (STD) Diagnosis Product

Table 83. Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 84. Biocartis Recent Development

Table 85. BioMerieux Company Details

Table 86. BioMerieux Business Overview

Table 87. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Product

Table 88. BioMerieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 89. BioMerieux Recent Development

Table 90. Bio-Rad Company Details

Table 91. Bio-Rad Business Overview

Table 92. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product

Table 93. Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 94. Bio-Rad Recent Development

Table 95. Cepheid Company Details

Table 96. Cepheid Business Overview

Table 97. Cepheid Sexually Transmitted Disease (STD) Diagnosis Product

Table 98. Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 99. Cepheid Recent Development

Table 100. Danaher Company Details

Table 101. Danaher Business Overview

Table 102. Danaher Sexually Transmitted Disease (STD) Diagnosis Product

Table 103. Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 104. Danaher Recent Development

Table 105. DiaSorin Company Details

Table 106. DiaSorin Business Overview

Table 107. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Product

Table 108. DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 109. DiaSorin Recent Development

Table 110. Quidel Company Details

Table 111. Quidel Business Overview

Table 112. Quidel Sexually Transmitted Disease (STD) Diagnosis Product

Table 113. Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 114. Quidel Recent Development

Table 115. GenMark Diagnostics Company Details

Table 116. GenMark Diagnostics Business Overview

Table 117. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product

Table 118. GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 119. GenMark Diagnostics Recent Development

Table 120. Hologic Company Details

Table 121. Hologic Business Overview

Table 122. Hologic Sexually Transmitted Disease (STD) Diagnosis Product

Table 123. Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 124. Hologic Recent Development

Table 125. OraSure Technologies Company Details

Table 126. OraSure Technologies Business Overview

Table 127. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Product

Table 128. OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 129. OraSure Technologies Recent Development

Table 130. Qualigen Company Details

Table 131. Qualigen Business Overview

Table 132. Qualigen Sexually Transmitted Disease (STD) Diagnosis Product

Table 133. Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025) & (US$ Million)

Table 134. Qualigen Recent Development

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

Table 138. Authors List of This Report

List of Figures

Figure 1. Sexually Transmitted Disease (STD) Diagnosis Picture

Figure 2. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Type: 2024 VS 2031

Figure 4. Chlamydia testing Features

Figure 5. Syphilis testing Features

Figure 6. Gonorrhoea testing Features

Figure 7. Herpes simplex virus testing Features

Figure 8. Human papilloma virus testing Features

Figure 9. Human immunodeficiency virus testing Features

Figure 10. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Application: 2024 VS 2031

Figure 12. Government organizations Case Studies

Figure 13. Hospitals Case Studies

Figure 14. Diagnostic clinics Case Studies

Figure 15. Sexually Transmitted Disease (STD) Diagnosis Report Years Considered

Figure 16. Global Sexually Transmitted Disease (STD) Diagnosis Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Sexually Transmitted Disease (STD) Diagnosis Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Region: 2024 VS 2031

Figure 19. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Players in 2024

Figure 20. Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2024

Figure 22. North America Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2020-2031)

Figure 24. United States Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2020-2031)

Figure 28. Germany Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Share by Region (2020-2031)

Figure 36. China Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2020-2031)

Figure 44. Mexico Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Share by Country (2020-2031)

Figure 48. Turkey Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Sexually Transmitted Disease (STD) Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Abbott Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 54. Aposcience Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 55. BCR Diagnostics Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 56. BD Medical Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 57. Biocartis Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 58. BioMerieux Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 59. Bio-Rad Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 60. Cepheid Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 61. Danaher Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 62. DiaSorin Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 63. Quidel Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 64. GenMark Diagnostics Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 65. Hologic Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 66. OraSure Technologies Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 67. Qualigen Revenue Growth Rate in Sexually Transmitted Disease (STD) Diagnosis Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions